FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
A cheaper, easier-to-use version of Wegovy is coming to the US soon
Novo Nordisk får grønt lys til Wegovy-pille mod fedme i USA
Novo Nordisk weight-loss drug wins US approval as a daily pill
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
Jyske Bank: